enow.com Web Search

  1. Ads

    related to: memantine for dementia symptoms and treatment options list

Search results

  1. Results from the WOW.Com Content Network
  2. Memantine - Wikipedia

    en.wikipedia.org/wiki/Memantine

    There are likewise limited data to support memantine in the treatment of schizophrenia based on systematic reviews and meta-analyses. [75] [76] However, a 2019 systematic review and meta-analysis reported that memantine was effective in the treatment of the negative and cognitive symptoms of schizophrenia with medium to large effect sizes. [77]

  3. Memantine/donepezil - Wikipedia

    en.wikipedia.org/wiki/Memantine/donepezil

    Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the Alzheimer's type. [1] It contains memantine, as the hydrochloride, a NMDA receptor antagonist; and donepezil as the hydrochloride, an acetylcholinesterase inhibitor. [1] It is taken by mouth. [1]

  4. Category:Treatment of Alzheimer's disease - Wikipedia

    en.wikipedia.org/wiki/Category:Treatment_of...

    Pages in category "Treatment of Alzheimer's disease" The following 9 pages are in this category, out of 9 total. ... Memantine; Memantine/donepezil; P. Protollin; R.

  5. Category:Antidementia agents - Wikipedia

    en.wikipedia.org/wiki/Category:Antidementia_agents

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  6. List of psychotropic medications - Wikipedia

    en.wikipedia.org/wiki/List_of_psychotropic...

    Stelazine (trifluoperazine) – an antipsychotic used in the treatment of psychotic disorders, anxiety, and nausea caused by chemotherapy [2] Strattera (atomoxetine) – a non-stimulant medication used to treat ADHD; Suboxone (buprenorphine/naloxone) - a partial opioid agonist used in the treatment of opioid use disorder

  7. NMDA receptor - Wikipedia

    en.wikipedia.org/wiki/NMDA_receptor

    Memantine, a low-trapping NMDAR antagonist, is approved in the United States and Europe for the treatment of moderate-to-severe Alzheimer's disease, [128] and has now received a limited recommendation by the UK's National Institute for Health and Care Excellence for patients who fail other treatment options. [129]

  1. Ads

    related to: memantine for dementia symptoms and treatment options list